#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
The Cerebrovascular Surgery and Interventions Center at Boston Children's Hospital conducts ongoing research to find better tests and treatments for cavernous malformations (CMs) and other cerebrovascular conditions. Our clinical research is complemented by basic research on blood vessels in the Vascular Biology Program.
Our comprehensive patient database, representing the largest experience with pediatric cerebrovascular disease (CVD) in the world, allows us to track long-term outcomes in our patients with cavernous malformations, evaluate newly adopted interventions and improve our quality of care.
For example, we recently reviewed outcomes for 238 supratentorial lobar cavernous malformations in children coming to Boston Children's from 1997 to 2011, of which 83 cavernous malformations were removed surgically. For those cavernous malformations that caused symptoms, 98 percent were completely removed, and 96 percent of patients with seizures were seizure-free at follow-up. Read an abstract of the study.
Working with the Simulator Program at Boston Children's, Edward Smith, MD and Darren Orbach, MD, PhD, are pioneering the creation of precision 3D models of patients' brains and blood vessels, using data from their brain scans, to better understand their CVD condition and plan safe treatment Maneuvers. The models are created with digital guided 3D printers that lay down different types of molten plastic.
Neurosurgeon Edward Smith, MD, is beginning to identify telltale proteins in the urine of patients with cerebrovascular disorders. These "biomarkers" may help in diagnosing and monitoring CVD, reducing the need for children to travel to Boston Children's for follow-up imaging studies. Dr. Smith has already validated the utility of urine biomarkers of several kinds of brain tumors. Read more. See some of our published papers on CMs.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”